Neogene: AstraZeneca to Acquire Neogene Therapeutics, for up to $320M

AstraZeneca acquired Neogene Therapeutics, a Santa Monica, CA and Amsterdam, Netherlands-based clinical-stage biotechnology company. AstraZeneca will acquire all outstanding equity of Neogene Therapeutics for a total consideration of up to $320m, on a cash and debt free basis. This will include an initial payment of $200m on deal closing, and a further up to $120m [...]The post AstraZeneca to Acquire Neogene Therapeutics, for up to $320M appeared first on FinSMEs.